HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
Shuang‐Yan Tang, Feng Shi, Yi Xiao, Hongjie Cai, Ping Ma, Yuan-Min Zhou, Zhiqiang Wu, Song Chen, Wenbo Guo
Topics & Concepts
MedicineHepatocellular carcinomaLenvatinibInternal medicineGastroenterologyHepatologyPropensity score matchingAdverse effectPortal vein thrombosisRetrospective cohort studyOncologyPortal veinSorafenibHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesCancer Mechanisms and Therapy